Fieldview Capital Management LLC Makes New Investment in Colgate-Palmolive Company $CL

Fieldview Capital Management LLC purchased a new position in shares of Colgate-Palmolive Company (NYSE:CL) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 59,549 shares of the company’s stock, valued at approximately $4,760,000. Colgate-Palmolive accounts for 0.8% of Fieldview Capital Management LLC’s holdings, making the stock its 17th largest position.

Several other institutional investors and hedge funds have also recently modified their holdings of CL. Inceptionr LLC acquired a new position in Colgate-Palmolive during the 3rd quarter worth about $628,000. Private Advisor Group LLC grew its position in Colgate-Palmolive by 2.4% in the 3rd quarter. Private Advisor Group LLC now owns 79,095 shares of the company’s stock valued at $6,323,000 after acquiring an additional 1,826 shares in the last quarter. Diversify Advisory Services LLC increased its stake in Colgate-Palmolive by 33.3% during the third quarter. Diversify Advisory Services LLC now owns 17,470 shares of the company’s stock worth $1,310,000 after purchasing an additional 4,367 shares during the period. B. Metzler seel. Sohn & Co. AG lifted its position in shares of Colgate-Palmolive by 1.2% during the third quarter. B. Metzler seel. Sohn & Co. AG now owns 448,798 shares of the company’s stock worth $35,877,000 after purchasing an additional 5,471 shares in the last quarter. Finally, Vinva Investment Management Ltd lifted its position in shares of Colgate-Palmolive by 27.4% during the third quarter. Vinva Investment Management Ltd now owns 114,565 shares of the company’s stock worth $9,211,000 after purchasing an additional 24,647 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 0.9%

Shares of Colgate-Palmolive stock opened at $93.55 on Monday. The company has a quick ratio of 0.54, a current ratio of 0.83 and a debt-to-equity ratio of 18.82. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $100.18. The company has a market capitalization of $75.41 billion, a P/E ratio of 35.71, a P/E/G ratio of 4.22 and a beta of 0.28. The company has a 50 day moving average of $88.98 and a 200 day moving average of $83.03.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 30th. The company reported $0.95 EPS for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The company had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. During the same period in the prior year, the firm posted $0.91 EPS. The company’s quarterly revenue was up 5.8% compared to the same quarter last year. As a group, research analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st were paid a $0.52 dividend. The ex-dividend date was Wednesday, January 21st. This represents a $2.08 dividend on an annualized basis and a yield of 2.2%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 79.39%.

Insiders Place Their Bets

In other news, COO Panagiotis Tsourapas sold 15,000 shares of the firm’s stock in a transaction dated Thursday, February 12th. The stock was sold at an average price of $97.81, for a total transaction of $1,467,150.00. Following the sale, the chief operating officer owned 10,415 shares of the company’s stock, valued at approximately $1,018,691.15. This trade represents a 59.02% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Stanley J. Sutula III sold 97,843 shares of the business’s stock in a transaction that occurred on Wednesday, February 4th. The stock was sold at an average price of $94.27, for a total value of $9,223,659.61. Following the sale, the chief financial officer owned 55,310 shares of the company’s stock, valued at approximately $5,214,073.70. The trade was a 63.89% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 184,683 shares of company stock valued at $17,486,693 in the last three months. Corporate insiders own 0.41% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on CL. Wells Fargo & Company lifted their price objective on shares of Colgate-Palmolive from $86.00 to $94.00 and gave the company an “equal weight” rating in a report on Sunday, February 1st. UBS Group increased their target price on shares of Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a report on Wednesday, January 14th. Piper Sandler raised their price target on shares of Colgate-Palmolive from $88.00 to $96.00 and gave the company an “overweight” rating in a research report on Friday, January 30th. Deutsche Bank Aktiengesellschaft upped their price objective on Colgate-Palmolive from $83.00 to $90.00 and gave the stock a “hold” rating in a research report on Monday, February 2nd. Finally, Bank of America increased their price objective on Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a research note on Monday, February 2nd. Eleven analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat, Colgate-Palmolive has a consensus rating of “Moderate Buy” and a consensus target price of $94.75.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.